Oncology

Top Story

FDA grants priority review to Opdivo for advanced liver cancer

May 24, 2017

The FDA granted priority review to nivolumab for the treatment of hepatocellular carcinoma, according to the drug’s manufacturer.

The designation applies to use of nivolumab (Opdivo, Bristol-Myers Squibb), a PD-1 immune checkpoint inhibitor, in patients previously treated with sorafenib (Nexavar, Bayer).

In the Journals

HCC in presence of HCV decreases cure rate in DAA treatment

May 24, 2017
Patients with hepatocellular carcinoma and hepatitis C were less likely to achieve sustained virologic response while receiving direct-acting antiviral therapy compared…
In the Journals

Early-onset HCC linked to HBV in South American patients

May 24, 2017
Hepatocellular carcinoma was linked to patients with hepatitis B in South America, particularly those younger than 50 years, according to results of a retrospective…
In the Journals

Liver tumor sizes at criteria margins may be subject to inaccurate reports

May 19, 2017
Researchers found evidence suggesting that tumor sizes at the margins of hepatocellular carcinoma-related transplantation criteria may be subject to inaccurate…
CME

HCV Updates and Case Challenges for the Rapidly Changing Landscape

This activity is supported by an educational grant from Merck & Co., Inc.

In the past few years, significant progress has been made in the treatment of chronic hepatitis C virus (HCV). Highly…
More »
GI Bookshelf

Chapter 50: Gastrointestinal Complications Of Bariatric Surgery

From Clinical Nutrition in Gastrointestinal Disease
More »
Featured
International Liver Congress

International Liver Congress

Video
Meeting News Coverage

VIDEO: ILC presentations focus on advances in hepatocellular carcinoma

April 12, 2014
More »
FDA News

FDA grants priority review to Opdivo for advanced liver cancer

May 24, 2017
The FDA granted priority review to nivolumab for the treatment of hepatocellular carcinoma, according to the drug’s manufacturer. The…

In the Journals

HCC in presence of HCV decreases cure rate in DAA treatment

May 24, 2017
Patients with hepatocellular carcinoma and hepatitis C were less likely to achieve sustained virologic response while receiving direct-acting…

In the Journals

Early-onset HCC linked to HBV in South American patients

May 24, 2017
Hepatocellular carcinoma was linked to patients with hepatitis B in South America, particularly those younger than 50 years, according to results of…

In the Journals

Liver tumor sizes at criteria margins may be subject to inaccurate reports

May 19, 2017
Researchers found evidence suggesting that tumor sizes at the margins of hepatocellular carcinoma-related transplantation criteria may be subject to…

Meeting NewsPerspective

Adjuvant capecitabine therapy extends survival in biliary tract cancer

May 18, 2017
The use of capecitabine as adjuvant therapy significantly extended survival of patients with biliary tract cancer, according to results of the BILCAP…

Meeting News

Nivolumab shows promise for advanced liver cancer

April 28, 2017
Nivolumab appeared safe and effective in patients with advanced liver cancer who did not respond to sorafenib, according to results from the…

FDA News

FDA expands approval of Stivarga to include liver cancer

April 27, 2017
The FDA expanded the approval of regorafenib to include the treatment of patients with hepatocellular carcinoma who have been previously treated with…

Tiziana announces phase 2 safety trial of milciclib for treating HCC

April 24, 2017
Tiziana announced approval in Israel of a phase 2 clinical trial to test the safety of milciclib, a novel inhibitor of cell cycle dependent kinases…

Meeting News

Sorafenib, selective internal radiation yield similar survival in HCC

April 22, 2017
AMSTERDAM — Selective internal radiation therapy failed to best Nexavar in overall survival but did yield improvements in other parameters…

Meeting News

One-third of UK adolescents with HCV developed serious liver disease

April 21, 2017
AMSTERDAM — Approximately one-third of children under 18 years in the United Kingdom with hepatitis C developed serious long-term liver…

More Headlines »
Advertisement
Advertisement